Total Allowable Error Table
Total Allowable Error Table (Updated 20 juin24)
| Analyte | Fluid | Method | Target Value | Source |
|---|---|---|---|---|
| 17-Hydroxyprogesterone | Serum | ±2,0 nmol/L or 20% if > 10,0 nmol/L | 5 RCPA | |
| 3-Methoxytyramine (3MT) | Urine | ±15 nmol/L or ± 15% if > 100 nmol/L | 5 RCPA | |
| 4-hydroxy-3-methoxy-mandelate, (HMMA) | Urine | ±6 μmol/L or 15% if > 40 μmol/L | 5 RCPA | |
| 5HIAA | Urine | ±8 μmol/L or 20% if > 40 μmol/L | 5 RCPA | |
| a1-Antitrypsin (α1AT) | Serum | ±0,10 g/L or 20% if > 0,5 g/L | 5 RCPA | |
| Acetaminophen (Paracetamol) | Serum | ±15% or 3 µg/mL (greater) | 1 CLIA, 2 WSLH, 3 CAP | |
| Acetaminophen (Paracetamol) | Serum | ±15% or 2,5 µg/mL (greater) | 4 AAB | |
| Acetaminophen (Paracetamol) | Serum | ±3,0 mg/L or 10% if > 30,0 mg/L | 5 RCPA | |
| Activated Clotting Time (ACT) | Plasma | ±20% | 2 WSLH | |
| Adrenaline | Urine | ±30 nmol/L or 30% if > 100 nmol/L | 5 RCPA | |
| Adrenocorticotropic Hormone (ACTH) | Serum | ±2,0 pmol/L or 10% if > 20 pmol/L | 5 RCPA | |
| Alanine Aminotransferase (ALT) | Serum | ±15% or 6 U/L (greater) | 1 CLIA, 2 WSLH, 3 CAP | |
| Alanine Aminotransferase (ALT) | Serum | ±20% | 4 AAB | |
| Alanine Aminotransferase (ALT) | Serum | ±5 U/L or 12% if > 40 U/L | 5 RCPA | |
| Albumin | Serum | ±8% | 1 CLIA, 2 WSLH, 3 CAP | |
| Albumin | Body Fluids | ±10% | 2 WSLH | |
| Albumin | Serum | ±10% | 4 AAB | |
| Albumin | Serum, Body Fluids | ±2,0 g/L or 6% if > 33 g/L | 5 RCPA | |
| Albumin | CSF | ±0,02 g/L or 20% if > 0,1 g/L | 5 RCPA | |
| Albumin | Urine | ±4,0 mg/L or 20% if > 20,0 mg/L | 5 RCPA | |
| Alcohol (ETOH) | Serum | ±20% | 1 CLIA, 2 WSLH | |
| Alcohol (ETOH) | Serum | ±25% | 4 AAB | |
| Alcohol (ETOH) | Serum | ±2,0 mmol/L or 10% if > 20 mmol/L | 5 RCPA | |
| Aldosterone | Serum | ±24 pmol/L or 15% if > 160 pmol/L | 5 RCPA | |
| Alkaline Phosphatase (ALP) | Serum | ±20% | 1 CLIA, 2 WSLH, 3 CAP | |
| Alkaline Phosphatase (ALP) | Serum | ±30% | 4 AAB | |
| Alkaline Phosphatase (ALP) | Serum | ±15 U/L or 12% if > 125 U/L | 5 RCPA | |
| Alpha 1 Antitrypsin | Serum | ±20% | 1 CLIA | |
| Alpha-fetoprotein (AFP) | Serum | ±20% | 1 CLIA, 2 WSLH | |
| Alpha-fetoprotein (AFP) | Serum | ±2 kIU/L or 12% if > 17 kIU/L | 5 RCPA | |
| Aluminum | Serum | ±0,08 μmol/L or 20% if > 0,40 μmol/L | 5 RCPA | |
| Amikacin | Serum | ±3 SD or 10% (greater) | 3 CAP | |
| Amikacin | Serum | ±2 mg/L or 10% if > 19,9 mg/L | 5 RCPA | |
| Aminolaevulinic Acid (ALA) | Urine | ±8 μmol/L or 25% if > 32 μmol/L | 5 RCPA | |
| Amiodarone | Serum | ±0,1 mg/L or 10% if > 1,3 mg/L | 5 RCPA | |
| Amitriptyline | Serum | ±3,0 μg/L or 10% if > 28,0 μg/L | 5 RCPA | |
| Ammonia | Serum | ±5% or 10 µmol/L (greater) | 4 AAB | |
| Ammonia | Serum | ±5 μmol/L or 10% if > 50 μmol/L | 5 RCPA | |
| Amylase | Serum | ±20% | 1 CLIA, 2 WSLH, 3 CAP | |
| Amylase | Serum | ±30% | 4 AAB | |
| Amylase | Body Fluids, Urine | ±30% | 2 WSLH | |
| Amylase | Serum | ±10 U/L or 10% if > 100 U/L | 5 RCPA | |
| Amylase | Body Fluids | ±20 U/L or 20% if > 100 U/L | 5 RCPA | |
| Androstenedione | Serum | ±1,5 nmol/L or 15% if > 10 nmol/L | 5 RCPA | |
| Angiotensin Converting Enzyme (ACE) | Serum | ±1,0 or 10% if > 10,0 U/L | 5 RCPA | |
| Antinuclear antibody (ANA) | Serum | ±2 dilutions or positive or negative | 1 CLIA | |
| Antistreptolysin O (ASO) | Serum | ±2 dilutions or positive or negative | 1 CLIA | |
| Antithrombin, Functional (AT) | Plasma | ±10% or 25% if > 40% | 5 RCPA | |
| Anti HIV (Human Immunodeficiency virus) | Serum | Reactive (positive) or nonreactive (negative) | 1 CLIA | |
| Anti Xa | Plasma | ±25 ng/mL or 25% if > 100 ng/mL | 5 RCPA | |
| Apolipoprotein A1 | Serum | ±0,2 g/L or 10% if > 2,0 g/L | 5 RCPA | |
| Apolipoprotein B | Serum | ±0,2 g/L or 10% if > 2,0 g/L | 5 RCPA | |
| Arsenic, Total | Urine | ±50 nmol/L or 10% if > 500 nmol/L | 5 RCPA | |
| Arsenic, Total | WB | ±10 nmol/L or 10% if > 100 nmol/L | 5 RCPA | |
| Aspartate Aminotransferase (AST) | Serum | ±15% or 6 U/L (greater) | 1 CLIA, 2 WSLH, 3 CAP | |
| Aspartate Aminotransferase (AST) | Serum | ±20% | 4 AAB | |
| Aspartate Aminotransferase (AST) | Serum | ±5 U/L or 12% if > 40 U/L | 5 RCPA | |
| Basophile, count | WB | ±3% or 30% if > 10% | 5 RCPA | |
| Beta-2 microglobulin (B2M) | Serum | ±0,2 mg/L or 10% if > 2,0 mg/L | 5 RCPA | |
| Beta Carotene | Serum | ±0,4 μmol/L or 25% if > 2,0 μmol/L | 5 RCPA | |
| Bile Acids, Total | Serum | ±4 μmol/L or 10% if > 40 μmol/L | 5 RCPA | |
| Bilirubin, Direct or Conjugated (DBIL) | Serum | ±0,4 mg/dL or 20% (greater) | 2 WSLH, 3 CAP | |
| Bilirubin, Direct or Conjugated (DBIL) | Serum | ±3 μmol/L or 20% if > 15 μmol/L | 5 RCPA | |
| Bilirubin, Neonatal (TBIL) | Serum | ±20% or 0,4 mg/dL (greater) | 4 AAB | |
| Bilirubin, Neonatal (TBIL) | Serum | ±8 μmol/L or 10% if > 80 μmol/L | 5 RCPA | |
| Bilirubin, Total | Serum | ±20% or 0,4 mg/dL (greater) | 1 CLIA, 2 WSLH, 3 CAP, 4 AAB | |
| Bilirubin, Total | Serum | ±3 μmol/L or 12% if > 25 μmol/L | 5 RCPA | |
| Bilirubin, Total | CSF | ±0,12 μmol/L or 20% if > 0,6 μmol/L | 5 RCPA | |
| B-natriuretic Peptide (BNP) | Serum | ±30% | 1 CLIA, 2 WSLH | |
| B-natriuretic Peptide (BNP) | Serum | ±2 SD or 25% (greater) | 4 AAB | |
| B-natriuretic Peptide (BNP) | Serum | ±20 ng/L or 20% if > 100 ng/L | 5 RCPA | |
| B-natriuretic Peptide, Pro (proBNP) | Serum | ±30% | 2 WSLH | |
| B-natriuretic Peptide, Pro (proBNP) | Serum | ±25% | 4 AAB | |
| B-natriuretic Peptide, Pro (proBNP) | Serum | ±25 ng/L or 20% if > 125 ng/L | 5 RCPA | |
| C Peptide | Serum | ±0,15 nmol/L or 12% if > 1,25 nmol/L | 5 RCPA | |
| C1 Inhibitor, Esterase (C1inh) | Serum | ±0,03 g/L or 15% if > ±0,2 g/L | 5 RCPA | |
| Cadmium | Urine, WB | ±1 mg/dL or 15% | 2 WSLH | |
| Cadmium | Urine, WB | ±3 nmol/L or 15% if > 20 nmol/L | 5 RCPA | |
| Caffeine | Serum | ±3 SD or 10% (greater) | 3 CAP | |
| Calcitonin | Serum | ±2 ng/L or 10% if > 20 ng/L | 5 RCPA | |
| Calcium - Total | Serum | ±1,0 mg/dL | 1 CLIA, 2 WSLH, 3 CAP, 4 AAB | |
| Calcium - Total | Urine | ±10% or 1 mg/dL | 2 WSLH | |
| Calcium - Total | Serum | ±0,1 mmol/L or 4% if > 2,5 mmol/L | 5 RCPA | |
| Calcium - Total | Urine | ±0,2 mmol/L or 10% if > 2,0 mmol/L | 5 RCPA | |
| Calcium, Ionized | Serum | ±0,13 mmol/L | 2 WSLH | |
| Calcium, Ionized | Serum | ±0,04 mmol/L or 4% if > 1,00 mmol/L | 5 RCPA | |
| Cancer Antigen (CA) 125 | Serum | ±6 kU/L or 12% if > 50 kU/L | 5 RCPA | |
| Cancer Antigen (CA) 15-3 | Serum | ±2 SD or 30% (greater) | 4 AAB | |
| Cancer Antigen (CA) 15-3 | Serum | ±3 kU/L or 10% if > 30 kU/L | 5 RCPA | |
| Cancer Antigen (CA) 19-9 | Serum | ±2 SD or 30% (greater) | 4 AAB | |
| Cancer Antigen (CA) 19-9 | Serum | ±6 kU/L or 15% if > 40 kU/L | 5 RCPA | |
| Cancer Antigen (CA) 19-9 | Body Fluids | ±12 kU/L or 30% if > 40 kU/L | 5 RCPA | |
| Cancer Antigen (CA) 27,29 | Serum | ±2 SD or 30% (greater) | 4 AAB | |
| Carbamazepine | Serum | ±20% or 1,0 µg/mL (greater) | 1 CLIA, 2 WSLH, 3 CAP | |
| Carbamazepine | Serum | ±25% | 4 AAB | |
| Carbamazepine | Serum | ±0,5 mg/L or 10% if > 4,7 mg/L | 5 RCPA | |
| Carbamazepine, Free | Serum | ±3 SD or 10% (greater) | 3 CAP | |
| Carcinoembryonic Antigen (CEA) | Serum | ±15% or 1 ng/mL (greater) | 1 CLIA, 2 WSLH | |
| Carcinoembryonic Antigen (CEA) | Serum | ±1,2 ng/mL or 20% | 4 AAB | |
| Carcinoembryonic Antigen (CEA) | Serum | ±0,6 μg/L or 12% if > 5 μg/L | 5 RCPA | |
| Carcinoembryonic Antigen (CEA) | Body Fluids | ±1,2 μg/L or 24% if > 5,0 μg/L | 5 RCPA | |
| Carotenoids, Total | Serum | ±0,8 μmol/L or 25% if > 4,0 μmol/L | 5 RCPA | |
| CD3+ Alpha-beta% | WB | ±4,5% to 15% if > 30% | 5 RCPA | |
| CD3+% | WB | ±1,5% or 5% if > 30% | 5 RCPA | |
| CD3x109/L | WB | ±0.02x109/L or 20% if > 0.1x109/L | 5 RCPA | |
| CD4x109/L | WB | ±0.02x109/L or 20% if > 0.1x109/L | 5 RCPA | |
| CD3+/CD4+% | WB | ±3% or 7,5% if > 40% | 5 RCPA | |
| CD3+/CD8+% | WB | ±1,5% or 10% if > 15% | 5 RCPA | |
| CD3-CD16+% | WB | ±2% or 20% if > 10% | 5 RCPA | |
| CD3-CD56+% | WB | ±2% or 20% if > 10% | 5 RCPA | |
| CD3-CD16+56+% | WB | ±2% or 20% if > 10% | 5 RCPA | |
| CD8x109/L | WB | ±0.02x109/L or 20% if > 0.1x109/L | 5 RCPA | |
| CD19+% | WB | ±2% or 20% if > 10% | 5 RCPA | |
| CD19x109/L | WB | ±0.02x109/L or 20% if > 0.1x109/L | 5 RCPA | |
| CD34+, % | WB | ±0,05% or 25% if > 0,3% | 5 RCPA | |
| CD34+, Total | WB | ±5 μL or 25% if > 20 μL | 5 RCPA | |
| Ceruloplasmin | Serum | ±0,03 g/L or 15% if > 0,2 g/L | 5 RCPA | |
| Chloride | Serum | ±5% | 1 CLIA, 2 WSLH, 3 CAP, 4 AAB | |
| Chloride | Urine | ±10% | 2 WSLH | |
| Chloride | Serum | ±3 mmol/L or 3% if > 100 mmol/L | 5 RCPA | |
| Chloride | Sweat | ±2,0 mmol/L or 5% if > 40 mmol/L | 5 RCPA | |
| Chloride | Urine | ±4,0 mmol/L or 10% if > 40 mmol/L | 5 RCPA | |
| Cholesterol, HDL | Serum | ±20% or 6 mg/dL (greater) | 1 CLIA, 2 WSLH, 3 CAP | |
| Cholesterol, HDL | Serum | ±30% | 4 AAB | |
| Cholesterol, HDL | Serum | ±0,1 mmol/L or 12% if > 0,8 mmol/L | 5 RCPA | |
| Cholesterol, LDL | Serum | ±20% | 1 CLIA, 2 WSLH, 3 CAP | |
| Cholesterol, LDL | Serum | ±30% | 4 AAB | |
| Cholesterol, LDL | Serum | ±0,2 mmol/L or 10% if > 2,0 mmol/L | 5 RCPA | |
| Cholesterol, Total | Serum | ±10% | 1 CLIA, 2 WSLH, 3 CAP, 4 AAB | |
| Cholesterol, Total | Body Fluids | ±10% | 2 WSLH | |
| Cholesterol, Total | Serum | ±0,3 mmol/L or 6% if > 5,0 mmol/L | 5 RCPA | |
| Cholesterol, Total | Body Fluids | ±0,3 mmol/L or 12% if > 2,5 mmol/L | 5 RCPA | |
| Cholinesterase | Serum | ±500 U/L or 10% if > 5000 U/L | 5 RCPA | |
| Chromium | Serum, Urine, WB | ±3 nmol/L or 12% if > 25 nmol/L | 5 RCPA | |
| Clozapine | Serum | ±12 μg/L or 12% if > 100 μg/L | 5 RCPA | |
| CO2, Carbon Dioxide (Bicarbonate) | Serum | ±20% | 1 CLIA, 2 WSLH, 3 CAP, 4 AAB | |
| CO2, Carbon Dioxide (Bicarbonate) | Serum | ±2,0 mmol/L or 10% if > 20,0 mmol/L | 5 RCPA | |
| Cobalt | Plasma | ±1 nmol/L or 10% if > 10 nmol/L | 5 RCPA | |
| Cobalt | Urine | ±2 nmol/L or 10% if > 20 nmol/L | 5 RCPA | |
| Cobalt | WB | ±2 nmol/L or 10% if > 10 nmol/L | 5 RCPA | |
| Compatibility testing | Serum | 100% accuracy | 1 CLIA | |
| Complement C3 | Serum | ±15% | 1 CLIA | |
| Complement C3 | Serum | ±0,10 g/L or 10% if > 1,0 g/L | 5 RCPA | |
| Complement C4 | Serum | ±20% or 5 mg/dL (greater) | 1 CLIA | |
| Complement C4 | Serum | 0,02 g/L or 10% if > 0,2 g/L | 5 RCPA | |
| Conductivity | Sweat | ±2 mmol/L or 5% if > 50 mmol/L | 5 RCPA | |
| Copper | Serum | ±1,6 μmol/L or 8% if > 20,0 μmol/L | 5 RCPA | |
| Copper | Urine | ±0,05 μmol/L or 10% if > 0,50 μmol/L | 5 RCPA | |
| Cortisol | Serum | ±20% | 1 CLIA, 2 WSLH, 3 CAP | |
| Cortisol | Serum | ±25% | 4 AAB | |
| Cortisol | Serum | ±15 nmol/L or 15% if > 100 nmol/L | 5 RCPA | |
| Cortisol | Urine | ±30 nmol/L or 15% if > 200 nmol/L | 5 RCPA | |
| C-Reactive protein (CRP) | Serum | ±30% or 2 SD (greater) | 4 AAB | |
| C-Reactive protein (CRP) | Serum | ±0,8 mg/L or 20% if > 4,0 mg/L | 5 RCPA | |
| C-Reactive protein (CRP), High Sensitivity | Serum | ±30% or 1 mg/L (greater) | 1 CLIA, 2 WSLH, 4 AAB | |
| C-Reactive protein (CRP), High Sensitivity | Serum | ±0,6 mg/L or 20% if > 3,0 mg/L | 5 RCPA | |
| Creatine Kinase (CK) | Serum | ±20% | 1 CLIA, 2 WSLH, 3 CAP | |
| Creatine Kinase (CK) | Serum | ±30% | 4 AAB | |
| Creatine Kinase (CK) | Serum | ±15 U/L or 12% if > 125 U/L | 5 RCPA | |
| Creatine Kinase Isoenzyme (CKMB) | Serum | ±25% or 3 ng/mL (greater) or MB elevated (presence or absence) | 1 CLIA, 2 WSLH | |
| Creatine Kinase Isoenzyme (CKMB) | Serum | ±3 U/L or 3 μg/L or 20% if > 15 U/L or 15 μg/L | 5 RCPA | |
| Creatinine | Serum | ±10% or 0,2 mg/dL (greater) | 1 CLIA, 2 WSLH, 3 CAP | |
| Creatinine | Body Fluids, Urine | ±17% or 0,3 mg/dL | 2 WSLH | |
| Creatinine | Serum | ±0,3 mg/dL or 15% (greater) | 4 AAB | |
| Creatinine | Serum, Urine | ±17% | 4 AAB | |
| Creatinine | Serum | ±8,0 μmol/L or 8% if > 100 μmol/L | 5 RCPA | |
| Creatinine | Body Fluids | ±16,0 μmol/L or 16% if > 100 μmol/L | 5 RCPA | |
| Creatinine | Urine | ±0,5 mmol/L or 10% if > 5,0 mmol/L | 5 RCPA | |
| Cyclosporine | Serum | ±10 μg/L or 10% if > 100 μg/L | 5 RCPA | |
| d-Dimer | Plasma | ±15% | 2 WSLH | |
| d-Dimer | Plasma | ±2 SD or 30% (greater) | 4 AAB | |
| d-Dimer | Plasma | automated DD | ±0,25 DD mg/L or 50% if > 0,5 DD mg/L | 5 RCPA |
| d-Dimer | Plasma | automated FEU | ±0,5 FEU mg/L or 50% if > 1,0 FEU mg/L | 5 RCPA |
| DHEA Sulfate | Serum | ±30% or 2 SD (greater) | 4 AAB | |
| DHEA Sulfate | Serum | ±1,2 μmol/L or 12% if > 10 μmol/L | 5 RCPA | |
| Digoxin | Serum | ±15% or 0,2 ng/mL (greater) | 1 CLIA, 2 WSLH, 3 CAP | |
| Digoxin | Serum | ±0,2 ng/dL or 20% (greater) | 4 AAB | |
| Digoxin | Serum | ±0,2 μg/L or 10% if > 1,6 μg/L | 5 RCPA | |
| Digoxin, Free | Serum | ±3 SD or 10% (greater) | 3 CAP | |
| Dihydropyrimidine dehydrogenase (DPYD) Free | Urine | ±15 nmol/L or 15% if > 80 nmol/L | 5 RCPA | |
| Direct Thrombin Inhibitor, (DTI) | Plasma | ±25 ng/mL or 25% if >100 ng/mL | 5 RCPA | |
| Disopyramide | Serum | ±3 SD or 10% (greater) | 3 CAP | |
| Dopamine | Urine | ±0,2 μmol/L or 10% if > 2,0 μmol/L | 5 RCPA | |
| Eosinophils, count | WB | ±3% or 30% if > 10% | 5 RCPA | |
| Erythrocyte Sedimentation Rate (ESR) | WB | ±3,0 mm/hr or 30% if > 10 mm/hr | 5 RCPA | |
| Estradiol | Serum | ±30% | 1 CLIA, 2 WSLH, 4 AAB | |
| Estradiol (Oestradiol) | Serum | ±25 pmol/L or 25% if > 100 pmol/L | 5 RCPA | |
| Estriol, Unconjugated (Oestriol) | Serum | ±0,9 nmol/L or 15% if > 6,0 nmol/L | 5 RCPA | |
| Ethosuximide | Serum | ±20% | 3 CAP | |
| Factor II, V, VII, IX, X, XI, XII | Plasma | ±3 IU/dL or 30% if > 10 IU/dL | 5 RCPA | |
| Factor VIII:C | Plasma | ±3% or 30% if > 10% | 5 RCPA | |
| Fecal Occult Blood (FOBT) | Stool | ±15 ng/mL or 15% if > 100 ng/mL | 5 RCPA | |
| Ferritin | Serum | ±20% | 1 CLIA, 2 WSLH, 3 CAP, 4 AAB | |
| Ferritin | Serum | ±4,0 μg/L or 15% if 27,0 μg/L | 5 RCPA | |
| Fibrinogen | Plasma | ±20% | 1 CLIA, 2 WSLH, 4 AAB | |
| Fibrinogen | Plasma | ±0,2 g/L or 25% if > 1,0 g/L | 5 RCPA | |
| Fluconazole | Serum | ±2,0 mg/L or 10% if > 20 mg/L | 5 RCPA | |
| Flucytosine | Serum | ±10 mg/L or 10% if > 100 mg/L | 5 RCPA | |
| Folate | Serum | ±30% or 1 ng/mL (greater) | 1 CLIA, 2 WSLH, 4 AAB | |
| Folate | Serum | ±1,5 nmol/L or 25% if > 6,0 nmol/L | 5 RCPA | |
| Folate, RBC | WB | ±80 nmol/L or 20% if > 400 nmol/L | 5 RCPA | |
| Follicle Stimulating Hormone (FSH) | Serum | ±18% or 2 IU/L (greater) | 1 CLIA, 2 WSLH, 4 AAB | |
| Follicle Stimulating Hormone (FSH) | Serum | ±1,0 IU/L or 10% if > 10,0 IU/L | 5 RCPA | |
| Fractional Carboxyhemoglobin | WB | ±1% or 20% if > 5% | 5 RCPA | |
| Fractional Methemoglobin | WB | ±2% or 10% if > 20% | 5 RCPA | |
| Fractional Oxyhemoglobin | WB | ±3% or 4% if > 75% | 5 RCPA | |
| Fructosamine | Serum | ±15 μmol/L or 6% if > 250 μmol/L | 5 RCPA | |
| Gamma glutamyl transferase (GGT) | Serum | ±15% or 5 U/L (greater) | 1 CLIA, 2 WSLH, 3 CAP | |
| Gamma glutamyl transferase (GGT) | Serum | ±2 SD or 15% (greater) | 4 AAB | |
| Gamma glutamyl transferase (GGT) | Serum | ±5 U/L or 12% if > 40 U/L | 5 RCPA | |
| Gastrin | Serum | ±10 pmol/L or 10% if > 100 pmol/L | 5 RCPA | |
| Gentamicin | Serum | ±25% | 1 CLIA, 2 WSLH, 3 CAP | |
| Gentamicin | Serum | ±25% or 1,0 µg/mL (greater) | 4 AAB | |
| Gentamicin | Serum | ±0,2 mg/L or 10% if > 2,0 mg/L | 5 RCPA | |
| Glucose | Serum | ±8% or 6 mg/dL (greater) | 1 CLIA, 2 WSLH, 3 CAP | |
| Glucose | Body Fluids, CSF, Urine | ±10% | 2 WSLH | |
| Glucose | WB | ±20% or 15 mg/dL | 2 WSLH | |
| Glucose | Serum | ±6 mg/dL or 10% (greater) | 4 AAB | |
| Glucose | WB | ±6 mg/dL or 20% (greater) | 4 AAB | |
| Glucose | Serum, Body Fluids | ±0,4 mmol/L or 8% if > 5,0 mmol/L | 5 RCPA | |
| Glucose | CSF | ±0,2 mmol/L or 10% if > 2,0 mmol/L | 5 RCPA | |
| Glucose | Urine | ±1,0 mmol/L or 10% if > 10,0 mmol/L | 5 RCPA | |
| Glucose-6-phosphate-1-dehydrogenase (G6PD) | WB | ±3,0 U/g Hb or 30% if > 10 U/g Hb | 5 RCPA | |
| Growth Hormone | Serum | ±1,0 mU/L or 15% if > 7,0 mU/L | 5 RCPA | |
| Haptoglobin | Serum | ±0,1 g/L or 10% if > 0,8 g/L | 5 RCPA | |
| Hematocrit | WB | ±4% | 1 CLIA, 2 WSLH | |
| Hematocrit | WB | ±6 mg/dL or 20% (greater) | 4 AAB | |
| Hematocrit | WB | ±4% or 20% if > 20% | 5 RCPA | |
| Hemoglobin | WB | ±4% | 1 CLIA, 2 WSLH | |
| Hemoglobin | WB | ±7% | 4 AAB | |
| Hemoglobin | WB | ±5 g/L or 5% if > 100 g/L | 5 RCPA | |
| Hemoglobin A1c (Glycohemoglobin) | WB | ±8% | 1 CLIA, 2 WSLH | |
| Hemoglobin A1c (Glycohemoglobin) | WB | ±5% | 4 AAB | |
| Hemoglobin A1c (Glycohemoglobin) | WB | IFCC | ±4 mmol/mol or 8% if > 45 mmol/mol | 5 RCPA |
| Hemoglobin A1c (Glycohemoglobin) | WB | NGSP | ±0,4% or 6% if > 6,7% | 5 RCPA |
| Hemoglobin, A2 | WB | ±0,3% or 10% if > 2,0 | 5 RCPA | |
| Hemoglobin, F | WB | ±0,5% or 30% if > 1,5% | 5 RCPA | |
| Hemoglobin, Variant | WB | ±4% or 20% if > 20,0% | 5 RCPA | |
| Hemolysis, Serum Index | Serum | ±8 mg/dL or 10% if > 80 mg/dL | 5 RCPA | |
| Hepatitis (Anti-HBc, HBsAg, HBeAg, Anti-HCV) | Serum | Reactive (positive) or nonreactive (negative) | 1 CLIA, 2 WSLH | |
| Hepatitis, Surface Antibody (Anti-HBs) | Serum | Reactive (positive) or nonreactive (negative) | 1 CLIA, 2 WSLH | |
| Homocysteine | Serum | ±30% | 4 AAB | |
| Homocysteine | Serum | ±1,5 μmol/L or 10% if > 15 μmol/L | 5 RCPA | |
| Homovanillic Acid (HVA) | Urine | ±6 μmol/L or 15% if > 40 μmol/L | 5 RCPA | |
| Human Chorionic Gonadotropin (HCG) | Serum | ±18% or 3 mIU/mL (greater) or positive or negative | 1 CLIA, 2 WSLH, 3 CAP | |
| Human Chorionic Gonadotropin (HCG) | Serum | ±18% or 2 SD (greater) | 4 AAB | |
| Human Chorionic Gonadotropin (HCG) | Serum | ±1,0 IU/L or 10% if > 10,0 IU/L | 5 RCPA | |
| Human Chorionic Gonadotropin (HCG) | Urine | ±5,0 IU/L or 10% if > 50 IU/L | 5 RCPA | |
| Hydroxyitraconazole | Serum | ±0,2 mg/L or 10% if > 2,0 mg/L | 5 RCPA | |
| Icterus, Serum Index | Serum | ±6,0 μmol/L or 25% if > 25,0 μmol/L | 5 RCPA | |
| IgA | Serum | ±20% | 1 CLIA | |
| IgA | Serum | ±0,06 g/L or 10% if > 0,6 g/L | 5 RCPA | |
| IgD | Serum | ±0,2 g/L or 20% if > 1,0 g/L | 5 RCPA | |
| IgE | Serum | ±20% | 1 CLIA | |
| IgE | Serum | ±20 kU/L or 20% if > 100 kU/L | 5 RCPA | |
| IgG | Serum | ±20% | 1 CLIA | |
| IgG | Serum | ±25% | 4 AAB | |
| IgG | Serum | ±0,6 g/L or 10% if > 6 g/L | 5 RCPA | |
| IgG | CSF | ±0,02 g/L or 20% if > 0,1 g/L | 5 RCPA | |
| IgM | Serum | ±20% | 1 CLIA | |
| IgM | Serum | ±0,08 g/L or 15% If > 0,5 g/L | 5 RCPA | |
| Immature granulocytes (IG's) | WB | ±3% or 30% if > 10% | 5 RCPA | |
| Infectious mononucleosis | Serum | ±2 dilutions or positive or negative | 1 CLIA, 2 WSLH | |
| INR | Plasma | ±15% | 1 CLIA, 2 WSLH, 4 AAB | |
| INR | Plasma | ±0,3 ratio or 15% if > 2,0 ratio | 5 RCPA | |
| Insulin | Serum | ±6 mU/L or 12% if > 5 mU/L | 5 RCPA | |
| Insulin-like Growth Factor (IGF-1) | Serum | ±3 nmol/L or 12% if > 25 nmol/L | 5 RCPA | |
| Insulin-like Growth Factor Binding Protein (IGFBP-3) | Serum | ±15 nmol/L or 15% if > 100 nmol/L | 5 RCPA | |
| Iodine | Urine | ±80 nmol/L or 10% if > 800 nmol/L | 5 RCPA | |
| Iron (Fe) | Serum | ±15% | 1 CLIA, 2 WSLH, 3 CAP | |
| Iron (Fe) | Serum | ±20% | 4 AAB | |
| Iron (Fe) | Serum, Urine | ±3,0 μmol/L or 12% if > 25,0 μmol/L | 5 RCPA | |
| Iron Binding Capacity, Total (IBC) | Serum | ±20% | 1 CLIA, 2 WSLH, 3 CAP, 4 AAB | |
| Iron Binding Capacity, Total (IBC) | Serum, Urine | ±20% | 4 AAB | |
| Iron Binding Capacity, Total (IBC) | Serum | ±4 μmol/L or 8% if > 50,0 μmol/L | 5 RCPA | |
| Iron Binding Capacity, Unsaturated (UIBC) | Serum | ±20% | 2 WSLH | |
| Itraconazole | Serum | ±0,1 mg/L or 10% if > 1,0 mg/L | 5 RCPA | |
| Lactate | Serum | ±0,2 mmol/L | 2 WSLH | |
| Lactate | CSF | ±10% | 2 WSLH | |
| Lactate | Serum | ±0,4 mmol/L or 3 SD (greater) | 3 CAP, 4 AAB | |
| Lactate | Serum | ±0,5 mmol/L or 12% if > 4,0 mmol/L | 5 RCPA | |
| Lactate | CSF | ±0,3 mmol/L or 10% if > 3,0 mmol/L | 5 RCPA | |
| Lactate | Body Fluids | ±1,0 mmol/L or 25% if > 4,0 mmol/L | 5 RCPA | |
| Lactate Dehydrogenase (LD, LDH) | Serum | ±15% | 1 CLIA, 2 WSLH, 3 CAP | |
| Lactate Dehydrogenase (LD, LDH) | Body Fluids | ±20% | 2 WSLH | |
| Lactate Dehydrogenase (LD, LDH) | Serum | ±20% | 4 AAB | |
| Lactate Dehydrogenase (LD, LDH) | Serum, Body Fluids | ±20 U/L or 8% if > 250 U/L | 5 RCPA | |
| Lead (Pb) | WB | ±10% or 2 µg/dL (greater) | 1 CLIA, 2 WSLH | |
| Lead (Pb) | WB | ±4 µg/dL or 10% (greater) | 4 AAB | |
| Lead (Pb) | Urine | ±50 nmol/L or 10% if > 500 nmol/L | 5 RCPA | |
| Lead (Pb) | WB | ±0,05 μmol/L or 10% if > 0,50 μmol/L | 5 RCPA | |
| Lidocaine | Serum | ±3 SD or 10% (greater) | 3 CAP | |
| Lipase | Serum | ±30% | 2 WSLH, 3 CAP, 4 AAB | |
| Lipase | Serum | ±12 U/L or 20% if > 60 U/L | 5 RCPA | |
| Lipase | Body Fluids | ±24 U/L or 40% if > 60 U/L | 5 RCPA | |
| Lipemia, Serum Index | Serum | ±26 mg/dL or 10% if > 263 mg/dL | 5 RCPA | |
| Lipoprotein (a) | Serum | ±0,06 g/L or 20% if > 0,3 g/L | 5 RCPA | |
| Lithium | Serum | ±15% or 0,3 mmol/L (greater) | 1 CLIA, 2 WSLH, 3 CAP | |
| Lithium | Serum | ±0,3 mmol/L or 20% (greater) | 4 AAB | |
| Lithium | Serum | ±0,2 mmol/L or 10% if > 2,0 mmol/L | 5 RCPA | |
| Luteinizing Hormone (LH) | Serum | ±20% | 1 CLIA, 2 WSLH, 3 CAP, 4 AAB | |
| Luteinizing Hormone (LH) | Serum | ±1,5 IU/L or 15% if > 10,0 IU/L | 5 RCPA | |
| Lymphocytes, count | WB | ±2% or 20% if > 10% | 5 RCPA | |
| Magnesium | Serum | ±15% | 1 CLIA, 2 WSLH, 3 CAP | |
| Magnesium | Urine | ±25% | 2 WSLH | |
| Magnesium | Serum | ±25% | 4 AAB | |
| Magnesium | Serum, WB | ±0,1 mmol/L or 8% if > 1,25 mmol/L | 5 RCPA | |
| Magnesium | Urine | ±0,3 mmol/L or 15% if > 2,0 mmol/L | 5 RCPA | |
| Magnesium | Urine | ±0,1 mmol/L or 8% if > 1,25 mmol/L | 5 RCPA | |
| Manganese | Serum | ±0,1 nmol/L or 8% if | 5 RCPA | |
| Manganese | Urine | ±3 nmol/L or 12% if > 25 nmol/L | 5 RCPA | |
| Manganese | WB | ±30 nmol/L or 12% if > 250 nmol/L | 5 RCPA | |
| Mean corpuscular hemoglobin (MCH) | WB | ±2 pg or 10% if > 20 pg | 5 RCPA | |
| Mean corpuscular hemoglobin concentration (MCHC) | WB | ±30 g/L or 10% if > than 300 g/L | 5 RCPA | |
| Mean corpuscular volume (MCV) | WB | ±5 fL or 10% if > 50 fL | 5 RCPA | |
| Mean platelet volume (MPV) | WB | ±2 fL or 20% if > 10 fL | 5 RCPA | |
| Metanephrine | Plasma | ±75 pmol/L or 15% if > 500 pmol/L | 5 RCPA | |
| Metanephrine | Urine | ±0,2 μmol/L or 20% if > 1,0 μmol/L | 5 RCPA | |
| Metanephrine, Free | Urine | ±30 nmol/L or 30% if > 100 nmol/L | 5 RCPA | |
| Methemoglobin | WB | ±0,003 | 2 WSLH | |
| Methotrexate | Serum | ±3 SD or 10% (greater) | 3 CAP | |
| Methotrexate | Serum | ±0,10 μg/L or 10% if > 1,00 μmol/L | 5 RCPA | |
| Methyoxytyramine | Plasma | ±36 pmol/L or 30% if > 120 pmol/L | 5 RCPA | |
| Mercury | Serum | ±30% or 3 ug/L | 2 WSLH | |
| Mercury | Serum, Urine, WB | ±9 nmol/L or 15% if > 60 nmol/L | 5 RCPA | |
| Microalbumin | Urine | ±10% | 2 WSLH | |
| Microalbumin | Urine | ±30% | 4 AAB | |
| Monocytes, count | WB | ±3% or 30% if > 10% | 5 RCPA | |
| Mycophenolate | Serum | ±0,10 μg/L or 10% if > 1,00 mg/L | 5 RCPA | |
| Myoglobin | Serum | ±2 SD or 30% (greater) | 4 AAB | |
| N-Acetylprocainamide (NAPA) | Serum | ±25% | 3 CAP | |
| Neuron-specific enolase (NSE) | Serum | ±2 μg/L or 10% if > 20 μg/L | 5 RCPA | |
| Neutrophil, count | WB | automated | ±1% or 10% if > 10,0% | 5 RCPA |
| Nickel | Urine | ±40 nmol/L or 10% if > 400 nmol/L | 5 RCPA | |
| Noradrenaline | Urine | ±75 nmol/L or 15% if > 500 nmol/L | 5 RCPA | |
| Normetanephrine | Plasma | ±200 pmol/L or 20% if > 1000 pmol/L | 5 RCPA | |
| Normetanephrine | Urine | ±0,4 μmol/L or 20% if > 2,0 μmol/L | 5 RCPA | |
| Normetanephrine, Free | Urine | ±40 nmol/L or 20% if > 200 nmol/L | 5 RCPA | |
| Nortriptyline | Serum | ±3,0 μg/L or 10% if > 26,0 μg/L | 5 RCPA | |
| N-Telopeptides | Urine | ±80 nmolBCE/L or 10% if > 700 nmolBCE/L | 5 RCPA | |
| Osmolality | Urine | ±10% | 2 WSLH | |
| Osmolality | Serum, Body Fluids | ±8 mmol/kg or 3% if > 266 mmol/kg | 5 RCPA | |
| Osmolality | Urine | ±6 mmol/kg or 2% if > 300 mmol/kg | 5 RCPA | |
| Pancreatic Amylase | Serum | ±30% | 3 CAP | |
| Parathyroid hormone (PTH) | Serum | ±30% | 1 CLIA, 2 WSLH, 4 AAB | |
| Parathyroid Hormone (PTH) | Serum | ±1,0 pmol/L or 12% if > 8,0 pmol/L | 5 RCPA | |
| Partial thromboplastin time (PTT), (aPTT) | Plasma | ±15% | 1 CLIA, 2 WSLH, 4 AAB | |
| Partial thromboplastin time (PTT), (aPTT) | Plasma | ±10 sec or 25% if > 40 sec | 5 RCPA | |
| pCO2 | WB | ±8% or 5 mmHg (greater) | 1 CLIA, 2 WSLH, 4 AAB | |
| pCO2 | WB | ±2 mm Hg or 6% if > 34,0 mm Hg | 5 RCPA | |
| pH | WB | ±0,04 | 1 CLIA, 2 WSLH, 4 AAB, 5 RCPA | |
| pH | Body Fluids | ±0,5 | 2 WSLH | |
| pH | Body Fluids | ±0,02 | 5 RCPA | |
| Phenobarbital | Serum | ±15% or 2 µg/mL (greater) | 1 CLIA, 2 WSLH, 3 CAP | |
| Phenobarbital | Serum | ±20% | 4 AAB | |
| Phenobarbitone | Serum | ±0,7 mg/L or 10% if > 7,0 mg/L | 5 RCPA | |
| Phenytoin | Serum | ±15% or 2 µg/mL (greater) | 1 CLIA, 2 WSLH, 3 CAP | |
| Phenytoin | Serum | ±25% | 4 AAB | |
| Phenytoin | Serum | ±0,8 mg/L or 10% if > 7,6 mg/L | 5 RCPA | |
| Phenytoin, Free | Serum | ±3 SD or 10% (greater) | 3 CAP | |
| Phosphate | Serum | ±0,06 mmol/L or 8% if > 0,75 mmol/L | 5 RCPA | |
| Phosphate | Urine | ±3 mmol/L or 15% if > 20 mmol/L | 5 RCPA | |
| Phosphorus | Serum | ±10% or 0,3 mg/dL (greater) | 1 CLIA, 2 WSLH, 3 CAP, 4 AAB | |
| Phosphorus | Urine | ±15% or 0,5 mg/dL | 2 WSLH | |
| Platelet count | WB | ±25% | 1 CLIA, 2 WSLH, 3 CAP, 4 AAB | |
| Platelet count | WB | ±25x109/L or 25% If > 100x109/L | 5 RCPA | |
| pO2 | WB | ±15% or 15 mmHg (greater) | 1 CLIA, 2 WSLH | |
| pO2 | WB | ±5 mm Hg or 6% if > 83 mm Hg | 5 RCPA | |
| Porphobilinogen | Urine | ±5 μmol/L or 25% if > 20 μmol/L | 5 RCPA | |
| Porphyrin, Total | Plasma | ±4 nmol/L or 20% if > 20 nmol/L | 5 RCPA | |
| Porphyrin, Total | Urine | ±60 nmol/ or 20% if > 300 nmol/L | 5 RCPA | |
| Porphyrin, Total | Fecal | ±40 μmol/kg or 20% if > 200 μmol/kg | 5 RCPA | |
| Porphyrin, Total RBC | WB | ±0,4 μmol/Lrc or 20% if > 2,0 μmol/Lrc | 5 RCPA | |
| Posaconazole | Serum | ±0,1 mg/L or 10% if > 1,0 mg/L | 5 RCPA | |
| Potassium (K) | Serum | ±0,3 mmol/L | 1 CLIA, 2 WSLH, 3 CAP | |
| Potassium (K) | Urine | ±10% | 2 WSLH | |
| Potassium (K) | Serum | ±0,5 mmol/L | 4 AAB | |
| Potassium (K) | Serum | ±0,2 mmol/L or 5% if > 4,0 mmol/L | 5 RCPA | |
| Potassium (K) | Body Fluids | ±0,4 mmol/L or 10% if > 4 mmol/L | 5 RCPA | |
| Potassium (K) | Urine | ±2 mmol/L or 10% > 20 mmol/L | 5 RCPA | |
| Prealbumin | Serum | ±5,0 mg/dL or 25% (greater) | 3 CAP | |
| Prealbumin | Serum | ±25% | 4 AAB | |
| Prealbumin | Serum | ±0,04 g/L or 20% if > 0,2 g/L | 5 RCPA | |
| Primidone | Serum | ±25% | 3 CAP | |
| Pro B-natriuretic Peptide (proBNP) | Serum | ±30% | 1 CLIA | |
| Procainamide | Serum | ±25% | 3 CAP | |
| Procalcitonin | Serum | ±0,05 ng/mL or 30% if > 0,15 ng/mL | 5 RCPA | |
| Progesterone | Serum | ±25% | 1 CLIA, 2 WSLH, 4 AAB | |
| Progesterone | Serum | ±2 nmol/L or 15% if > 10 nmol/L | 5 RCPA | |
| Prolactin | Serum | ±20% | 1 CLIA, 2 WSLH, 4 AAB | |
| Prolactin | Serum | ±40 mIU/L or 10% if > 400 mIU/L | 5 RCPA | |
| Prostate Specific Antigen (PSA) | Serum | ±20% or 0,2 ng/mL (greater) | 1 CLIA, 2 WSLH | |
| Prostate Specific Antigen (PSA) | Serum | ±0,9 ng/mL or 30% | 4 AAB | |
| Prostate Specific Antigen (PSA) | Serum, Urine | ±0,4 μg/L or 8% if > 5,0 μg/L | 5 RCPA | |
| Prostate Specific Antigen (PSA), Free | Serum | ±30% or 0,9 ng/mL | 2 WSLH | |
| Prostate Specific Antigen (PSA), Free | Serum | ±0,9 ng/mL or 30% | 4 AAB | |
| Prostate Specific Antigen (PSA), Free | Serum | ±0,2 μg/L or 15% if > 1,4 μg/L | 5 RCPA | |
| Protein, Total | Serum | ±8% | 1 CLIA, 2 WSLH, 3 CAP | |
| Protein, Total | Body Fluids, CSF, Urine | ±10% | 2 WSLH | |
| Protein, Total | Serum | ±10% | 4 AAB | |
| Protein, Total | Urine | ±44% | 4 AAB | |
| Protein, Total | Serum, Body Fluids | ±3,0 g/L or 5% if > 60 g/L | 5 RCPA | |
| Protein, Total | CSF | ±0,05 g/L or 10% if > 0,5 g/L | 5 RCPA | |
| Protein, Total | Urine | ±0,1 g/L or 10% if > 1,00 g/L | 5 RCPA | |
| Protein C, Functional | Plasma | ±12% or 20% if > 60% | 5 RCPA | |
| Protein S, Free Antigen | Plasma | ±10% or 25% if > 40% | 5 RCPA | |
| Protein S, Free Functional | Plasma | ±10% or 25% if > 40% | 5 RCPA | |
| Protein S, Total Antigen | Plasma | ±10% or 25% if > 40% | 5 RCPA | |
| Prothrombin Time (PT) | Serum | ±15% | 1 CLIA, 2 WSLH, 4 AAB | |
| Prothrombin Time (PT) | Plasma | ±2,0 sec or 20% if > 10 sec | 5 RCPA | |
| Quinidine | Serum | ±25% | 3 CAP | |
| RBC, Red Cell count, Erythrocyte Count | WB | automated differential | ±4% | 1 CLIA, 2 WSLH |
| RBC, Red Cell count, Erythrocyte Count | WB | quantitative | ±6% | 4 AAB |
| Red Cell Distribution Width (RDW) | WB | 2% or 20% if > 10% | 5 RCPA | |
| Reticulocyte count | WB | ±30% or 2 SD (greater) | 4 AAB | |
| Reticulocyte count | WB | automated % | ±1,0% or 10% if > 10% | 5 RCPA |
| Reticulocyte count | WB | automated absolute | ±10x109/L or 10% if > 100x109/L | 5 RCPA |
| Reticulocyte count | WB | manual % | ±0,6% or 30% if > 2% | 5 RCPA |
| Reticulocyte count | WB | manual absolute | ±21x109/L or 30% if > 70x109/L | 5 RCPA |
| Rheumatoid Factor (RF) | Serum | ±2 dilutions or positive or negative | 1 CLIA, 2 WSLH | |
| Rheumatoid Factor (RF) | Serum | ±12 IU/mL or 20% if > 60 IU/mL | 5 RCPA | |
| Rubella | Serum | ±2 dilutions or positive or negative or immune or nonimmune | 1 CLIA, 2 WSLH | |
| Salicylates | Serum | ±15% or 2 µg/mL (greater) | 1 CLIA, 2 WSLH, 3 CAP | |
| Salicylates | Serum | ±25% | 4 AAB | |
| Salicylates | Serum | ±14 mg/L or 10% if > 143,0 mg/L | 5 RCPA | |
| Selenium | Serum | ±0,18 μmol/L or 12% if > 1,50 μmol/L | 5 RCPA | |
| Selenium | Urine | ±0,06 μmol/L or 12% if > 0,50 μmol/L | 5 RCPA | |
| Selenium | WB | ±0,3 μmol/L or 12% if > 2,50 μmol/L | 5 RCPA | |
| Serotonin | Urine | ±0,2 μmol/L or 20% if > 1,0 μmol/L | 5 RCPA | |
| Sex hormone binding globulin (SHBG) | Serum | ±6 nmol/L or 12% if > 50 nmol/L | 5 RCPA | |
| Sirolimus | Serum | ±0,5 μg/L or 10% if > 5,0 μg/L | 5 RCPA | |
| Sodium (Na) | Serum | ±4 mmol/L | 1 CLIA, 2 WSLH, 3 CAP, 4 AAB | |
| Sodium (Na) | Urine | ±10% or 4 mmol/L | 2 WSLH | |
| Sodium (Na) | Serum | ±3 mmol/L or 2% if > 150 mmol/L | 5 RCPA | |
| Sodium (Na) | Body Fluids | ±6 mmol/L or 4% if > 150 mmol/L | 5 RCPA | |
| Sodium (Na) | Urine | ±4 mmol/L or 10% if > 40 mmol/L | 5 RCPA | |
| Specific Gravity | Urine | ±0,010 | 2 WSLH, 4 AAB | |
| T3 Free, (FT3) Triiodothyronine, Free | Serum | ±0,7 pmol/L or 20% if > 3,5 pmol/L | 5 RCPA | |
| T3, Total Triiodothyronine | Serum | ±30% | 1 CLIA, 2 WSLH, 3 CAP | |
| T3, Total Triiodothyronine | Serum | ±0,2 nmol/L or 15% if > 1,3 nmol/L | 5 RCPA | |
| T3 Uptake | Serum | ±18% | 1 CLIA, 2 WSLH, 3 CAP | |
| T4, Thyroxine | Serum | ±20% or 1,0 µg/dL (greater) | 1 CLIA, 2 WSLH, 3 CAP, 4 AAB | |
| T4, Thyroxine | Serum | ±12 nmol/L or 10% if > 120 nmol/L | 5 RCPA | |
| T4, Free Thyroxine, (FT4) | Serum | ±15% or 0,3 ng/dL (greater) | 1 CLIA, 2 WSLH, 3 CAP | |
| T4, Free Thyroxine, (FT4) | Serum | ±1,5 pmol/L or 12% if > 12,0 pmol/L | 5 RCPA | |
| Tacrolimus | Serum | ±0,5 μg/L or 10% if > 5,0 μg/L | 5 RCPA | |
| Testosterone | Serum | ±30% or 20 ng/dL (greater) | 1 CLIA, 2 WSLH, 4 AAB | |
| Testosterone | Serum | ±0,4 nmol/L or 15% if > 2,7 nmol/L | 5 RCPA | |
| Thallium | Serum, Urine | ±1 nmol/L or 10% if > 10 nmol/L | 5 RCPA | |
| Thallium | WB | ±2 nmol/L or 10% if > 10 nmol/L | 5 RCPA | |
| Theophylline | Serum | ±20% | 1 CLIA, 2 WSLH, 3 CAP | |
| Theophylline | Serum | ±25% | 4 AAB | |
| Theophylline | Serum | ±0,5 mg/L or 10% if > 5,4 mg/L | 5 RCPA | |
| Thrombin Time (TT) | Plasma | ±3,0 sec or 25% if > 12,0 sec | 5 RCPA | |
| Thyroglobulin | Serum | ±0,2 μg/L or 12% if > 1,7 μg/L | 5 RCPA | |
| Thyroid stimulating Hormone (TSH) | Serum | ±20% or 0,2 mIU/L (greater) | 1 CLIA, 2 WSLH, 3 CAP | |
| Thyroid Stimulating Hormone (TSH) | Serum | ±0,1 mU/L or 20% if > 0,5 mU/L | 5 RCPA | |
| Tobramycin | Serum | ±20% | 1 CLIA, 3 CAP | |
| Tobramycin | Serum | ±20% | 2 WSLH | |
| Tobramycin | Serum | ±0,2 mg/L or 10% if > 2,0 mg/L | 5 RCPA | |
| Transferrin | Serum | ±20% | 3 CAP | |
| Transferrin | Serum | ±10% | 4 AAB | |
| Transferrin | Serum | ±0,2 g/L or 8% if > 2,50 g/L | 5 RCPA | |
| Triglycerides | Serum | ±15% | 1 CLIA, 2 WSLH, 3 CAP | |
| Triglycerides | Body Fluids | ±25% | 2 WSLH | |
| Triglycerides | Serum | ±25% | 4 AAB | |
| Triglycerides | Serum | ±0,2 mmol/L or 12% if > 1,60 mmol/L | 5 RCPA | |
| Triglycerides | Body Fluids | ±0,3 mmol/L or 25% if > 1,2 mmol/L | 5 RCPA | |
| Troponin I | Serum | ±30% or 0,9 ng/mL (greater) | 1 CLIA, 2 WSLH | |
| Troponin I | Serum | ±30% | 4 AAB | |
| Troponin I | Serum | ±0,002 μg/L or 20% if > 0,010 μg/L | 5 RCPA | |
| Troponin I | Serum | ±0,01 μg/L or 20% if > 0,05 μg/L | 5 RCPA | |
| Troponin T | Serum | ±30% or 0,2 ng/mL (greater) | 1 CLIA, 2 WSLH | |
| Troponin T | Serum | ±30% | 4 AAB | |
| Troponin T | Serum | ±0,001 μg/L or 20% if > 0,050 μg/L | 5 RCPA | |
| Troponin T | Serum | ±10 ng/L or 20% if > 50 ng/L | 5 RCPA | |
| Tryptase | Serum | ±0,6 ug/L or 15% if > 4,0 ug/L | 5 RCPA | |
| Urate | Serum | ±0,030 mmol/L or 8% if > 0,380 mmol/L | 5 RCPA | |
| Urate | Body Fluids | ±0,06 mmol/L or 16% if > 0,38 mmol/L | 5 RCPA | |
| Urate | Urine | ±0,3 mmol/L or 15% if > 2 mmol/L | 5 RCPA | |
| Urea Nitrogen (BUN) | Serum | ±9% or 2 mg/dL (greater) | 1 CLIA, 2 WSLH, 3 CAP, 4 AAB | |
| Urea Nitrogen (BUN) | Urine | ±10% | 2 WSLH | |
| Urea Nitrogen (BUN) | Serum | ±0,5 mmol/L or 12% if > 4,0 mmol/L | 5 RCPA | |
| Urea Nitrogen (BUN) | Body Fluids | ±1,0 mmol/L or 24% if > 4,0 mmol/L | 5 RCPA | |
| Urea Nitrogen (BUN) | Urine | ±20 mmol/L or 10% if > 200 mmol/L | 5 RCPA | |
| Uric Acid | Serum | ±10% | 1 CLIA, 2 WSLH, 3 CAP | |
| Uric Acid | Serum | ±17% | 4 AAB | |
| Uric Acid | Urine | ±17% or 2 mg/dL | 2 WSLH | |
| Valproate | Serum | ±4,0 mg/L or 10% if > 36,0 mg/L | 5 RCPA | |
| Valproic Acid | Serum | ±20% | 1 CLIA, 2 WSLH, 3 CAP | |
| Valproic Acid | Serum | ±25% | 4 AAB | |
| Valproic Acid, Free | Serum | ±3 SD or 10% (greater) | 3 CAP | |
| Vanadium | Serum | ±1 nmol/L or 10% if > 10nmol/L | 5 RCPA | |
| Vanadium | Urine | ±2 nmol/L or 10% if > 10nmol/L | 5 RCPA | |
| Vancomycin | Serum | ±15% or 2 µg/mL (greater) | 1 CLIA, 2 WSLH, 3 CAP | |
| Vancomycin | Serum | ±25% or 1,0 μg/mL (greater) | 4 AAB | |
| Vancomycin | Serum | ±2,0 mg/L or 10% if > 20,3 mg/L | 5 RCPA | |
| Vitamin A | Serum | ±0,2 μmol/L or 12% if > 1,7 μmol/L | 5 RCPA | |
| Vitamin B1 | Serum | ±9 nmol/L or 15% if > 60 nmol/L | 5 RCPA | |
| Vitamin B2 | Serum | ±25 nmol/L or 10% if > 250 nmol/L | 5 RCPA | |
| Vitamin B6 | Plasma, WB | ±9 nmol/L or 15% if > 60 nmol/L | 5 RCPA | |
| Vitamin B12 | Serum | ±25% or 30 pg/mL (greater) | 1 CLIA, 2 WSLH | |
| Vitamin B12 | Serum | ±25% | 4 AAB | |
| Vitamin B12 | Serum | ±18 pmol/L or 15% if > 120 pmol/L | 5 RCPA | |
| Vitamin C | Serum | ±7 μmol/L or 20% if > 35 μmol/L | 5 RCPA | |
| Vitamin D3 | Serum | ±9 nmol/L or 15% if > 60 nmol/L | 5 RCPA | |
| Vitamin E | Serum | ±3 μmol/L or 12% if > 25 μmol/L | 5 RCPA | |
| von Willebrand Activity | Plasma | ±4% or 40% if > 10% | 5 RCPA | |
| von Willebrand factor, Antigen (vWF:Ag) | Plasma | ±3% or 30% if > 10% | 5 RCPA | |
| von Willebrand Collagen binding (vWF:CB) | Plasma | ±4% or 40% if > 10% | 5 RCPA | |
| von Willebrand Ristocetin Cofactor (vWF:rCo) | Plasma | ±4% or 40% if > 10% | 5 RCPA | |
| Voriconazole | Serum | ±0,2 mg/L or 10% if > 2,0 mg/L | 5 RCPA | |
| WBC, White Cell Count, Leukocyte count) | WB | automated differential | ±10% | 1 CLIA, 2 WSLH |
| WBC, White Cell Count, Leukocyte count) | WB | ±15% | 4 AAB | |
| WBC, White Cell Count, Leukocyte count) | WB | ±0.5x109/L or 10% if > 5,0 x109/L | 5 RCPA | |
| WBC Differential | WB | ±3SD based on the percentage of different types of white blood cells in the samples | 1 CLIA, 2 WSLH | |
| WBC Differential | WB | automated differential | ±3% or 30% if > 10% | 5 RCPA |
| Zinc | Serum, Urine | ±2 μmol/L or 10% if > 20,0 μmol/L | 5 RCPA | |
| Zinc | WB | ±6 μmol/L or 10% if > 60 μmol/L | 5 RCPA |
Sources
| Abbreviation | Source |
|---|---|
| 1 CLIA | CLIA – Federal Register |
| 2 WLSH | Wisconsin State Laboratory of Hygiene |
| 3 CAP | College of American Pathologists |
| 4 AAB | American Association of Bioanalysts |
| 5 RCPA | The Royal College of Pathologists of Australasia and the Australasian Clinical Biochemist association Quality Assurance Program |
